CA2 and glioblastoma: Here we show the potential of CA2 as a new potential target, as it is up-regulated in patient matched GBM tissue samples of primary and recurrent GBMs as well as in TMZ resistant primary GBM stem-like cells, where its inhibition by ACZ led to a resensitization of resistant cells.